Comment from National Health Council

Summary: The National Health Council (NHC), an organization representing nearly 200 health-related entities and patient groups, supports the FDA's effort to examine drug repurposing for unmet medical needs. They argue for a coordinated, patient-centered framework that prioritizes high-need disease areas, maintains rigorous evidentiary standards, and addresses practical barriers to patient access and labeling.